USP22 and glioma: The GSK3β-dependent phosphorylation of LSD1 contributes to the stability of the LSD1 protein, and phosphorylated LSD1 enhances its binding affinity with ubiquitin-specific protease 22 (USP22) in glioma stem cells, thereby promoting tumorigenicity [25].